Abstract
THE introduction of chlorothiazide (Table 1, I) in 1957 marked a major advance1 in the search for improved non-mercurial diuretics. Its advent was followed by a succession of more potent derivatives2. Clinically, however, apart from the size of dose, all these derivatives produced a similar therapeutic response3. One of the few disadvantages of these compounds is the loss of potassium which occurs concurrently with the excretion of sodium ions and can necessitate the administration of potassium supplements.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Novello, F. C., and Sprague, J. M., J. Amer. Chem. Soc., 79, 2028 (1957).
Schlittler, E., Destevens, G., and Werner, L., Angew. Chem., 1, 5, 235 (1962).
Wilson, G. M., Prescribers J., 1, No. 5, 55 (1961).
cf. Novello, F. C., et al., J. Org. Chem., 25, 970 (1960).
B.P. 36821/60.
B.P. 27562/61.
Blagg, C. R., (personal communication. 1962).
Dollery, C. T. (personal communication, 1962).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
CORNISH, E., LEE, G. & WRAGG, W. 5-Chloro-2-cyclohexyl-1-oxo-6-sulphamoyl Isoindoline : a New Diuretic. Nature 197, 1296–1297 (1963). https://doi.org/10.1038/1971296b0
Issue Date:
DOI: https://doi.org/10.1038/1971296b0
This article is cited by
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.